- Home
- RYTM vs EAT Comparison
RYTM vs EAT Comparison
Compare RYTM & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- EAT
- Stock Information
- Founded
- RYTM 2008
- EAT 1975
- Country
- RYTM United States
- EAT United States
- Employees
- RYTM N/A
- EAT N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- EAT Restaurants
- Sector
- RYTM Health Care
- EAT Consumer Discretionary
- Exchange
- RYTM Nasdaq
- EAT Nasdaq
- Market Cap
- RYTM 6.4B
- EAT 7.0B
- IPO Year
- RYTM 2017
- EAT N/A
- Fundamental
- Price
- RYTM $97.86
- EAT $126.56
- Analyst Decision
- RYTM Strong Buy
- EAT Buy
- Analyst Count
- RYTM 13
- EAT 15
- Target Price
- RYTM $109.77
- EAT $175.43
- AVG Volume (30 Days)
- RYTM 627.7K
- EAT 1.4M
- Earning Date
- RYTM 11-04-2025
- EAT 10-29-2025
- Dividend Yield
- RYTM N/A
- EAT N/A
- EPS Growth
- RYTM N/A
- EAT 144.71
- EPS
- RYTM N/A
- EAT 8.32
- Revenue
- RYTM $156,287,000.00
- EAT $5,384,200,000.00
- Revenue This Year
- RYTM $46.10
- EAT $6.91
- Revenue Next Year
- RYTM $60.39
- EAT $5.16
- P/E Ratio
- RYTM N/A
- EAT $15.21
- Revenue Growth
- RYTM 53.55
- EAT 21.95
- 52 Week Low
- RYTM $45.91
- EAT $81.30
- 52 Week High
- RYTM $106.52
- EAT $192.22
- Technical
- Relative Strength Index (RSI)
- RYTM 49.11
- EAT 27.18
- Support Level
- RYTM $95.88
- EAT $124.27
- Resistance Level
- RYTM $102.79
- EAT $129.41
- Average True Range (ATR)
- RYTM 3.20
- EAT 4.53
- MACD
- RYTM -0.25
- EAT -0.96
- Stochastic Oscillator
- RYTM 32.99
- EAT 9.76
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.